Anti-BIM Antibody, clone 2O18, ZooMAb^® Rabbit Monoclonal

rabbit (recombinant)

expressed in HEK 293 cells

unconjugated

purified antibody

primary antibodies

2O18, monoclonal
recombinant monoclonal

ZooMAb^® learn more

lyophilized

calculated mol wt 22.17 kDa
observed mol wt ~22 kDa

human, rat, mouse

pkg of 25 μL

Waste Prevention
Designing Safer Chemicals
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

recombinant expression
Learn more about Antibody Enhanced Validation

affinity binding assay: suitable
immunocytochemistry: suitable
immunohistochemistry: suitable
western blot: suitable

IgG

Aligned

ambient

2-8℃

ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.

Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.

Learn more about ZooMAb here.

Clone 2O18 is a ZooMAb rabbit recombinant monoclonal antibody that specifically detects Bcl-2-like protein 11 (BIM) protein. It targets an epitope within 19 amino acids from the N-terminal region.

KLH-conjugated linear peptide corresponding to 19 amino acids from the N-terminal region of human BIM.

Anti-BIM, clone 2O18 ZooMAb, Cat. No. ZRB1375, a recombinant Rabbit monoclonal antibody that targets BIM and is tested in Affinity Binding, Immunocytochemistry, Immunohistochemistry, and Western Blotting.
Western Blotting Analysis: A 1:10,000 dilution from a representative lot detected BIM in mouse spleen tissue lysate.

Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected BIM in human breast cancer and human lung cancer tissue sections.

Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected BIM in RAW264.7 cells.

Affinity Binding Assay: A representative lot of this antibody bound BIM peptide with a KD value of 3.9 x 10-7 in an affinity binding assay.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.

300 μg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

Bcl-2-like protein 11 (UniProt: O43521; also known as Bcl2-L-11, Bcl2-interacting mediator of cell death, BIM) is encoded by the BCL2L11 (also known as BIM) gene (Gene ID: 10018) in human. BIM is a pro-apoptotic member of the Bcl-2 family that plays an important role in Bax/Bak-mediated cytochrome c release and apoptosis in response to various intrinsic stimuli. Like other members of the Bcl-2 family, BIM possesses a hydrophobic C-terminus that helps it to localize to intracytoplasmic membranes. In normal healthy cells BIM is localized to the microtubule-associated dynein motor complex in association with the LC8 dynein light chain; however, when subjected to apoptosis stimuli, it dissociates from LC8 and translocates to the mitochondria where it interacts with Bcl-2 to block its anti-apoptotic activity. Its N-terminal plays a role keeping it bound to the cytoskeleton and removal of that allows it to translocate to mitochondria. BIM contains a BH3 motif (aa 148-162) that is essential for its interaction with Bcl-2 proteins. BIM can undergo phosphorylation at serine 69 by MAPK1/MAPK3 that leads to its interaction with tripartite motif containing 2 (TRIM2), an E3 ubiquitin ligase, and polyubiquitination, followed by proteasomal degradation. BIM-deficient mice display higher numbers of B cells, CD4 and CD8 single-positive T cells, macrophages and granulocytes in their periphery. BIM is also reported to be essential for the deletion of auto-reactive B and T cells. Lymphocytes lacking BIM are refractory to several stimuli, including cytokine deprivation, deregulated calcium ion flux. This ZooMAb recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: O Connor, L., et al (1998). EMBO J. 17(2); 384-395; Gogada, R., et al. (2013). J. Biol. Chem. 288(1); 368-381).

Recommend storage of lyophilized product at 2-8℃; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8℃, or -20℃ for long term storage. Avoid repeated freeze-thaws.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

11 - Combustible Solids

WGK 1